Center of excellence for bioavailability enhancement & drug delivery

Our team in Bend, Oregon (US) specializes, among other things, in addressing solubility challenges and modulating pharmacokinetics to meet target product profiles. The Bend site has specialized expertise, capabilities and infrastructure for spray-dried dispersion (SDD) technology which is increasingly being utilized for advancing poorly soluble molecules (BCS II compounds). A full range of oral drug delivery technologies and processing is also in place for modified and targeted release requirements in monolithic or multiparticulate formats.

The Bend site is staffed and equipped to support you throughout the entire lifecycle of your candidate, from preclinical and first in human to late-stage development and commercial production of drug product intermediates (SDD) and finished drug products.